A newly identified secreted protein by CAFs in HCC, follistatin-like 1 (FSTL1), was also found to have participated in stemness modulation and malignant transformation via activating AKT/mTOR/4EBP1 signaling [92]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.